AblaCare
The company, now operating as May Health, has developed the Anavi procedure, a one-time targeted ovarian ablation treatment designed to restore ovulation in patients with Polycystic Ovary Syndrome (PCOS). This outpatient procedure aims to lower androgen production without the use of hormones. It is currently being evaluated through clinical evidence and the REBALANCE study for individuals seeking to treat PCOS-related infertility.
Healthcare
Medical Devices
Women's Health
Funding summary
- Total raised
- €10.0M
- Funding rounds
- 1
Investors in AblaCare
Investors on record for AblaCare. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like AblaCare?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors